UK gets social media presence

Share this article:
The UK's Prescription Medicines Code of Practice Authority, which arbitrates drug industry self-regulation there, issued “informal guidance” on digital communications, and while it's more than FDA has offered, it's not much to go on.
The guidance, which takes the form of a Q&A, is mainly an interpretation of the industry's Code of Practice applied to social media and the internet. Short version: as in any other medium, companies can communicate only non-promotional information about products to the public, and only in response to a direct inquiry. However, the guidance does suggest that companies could post more basic product info on their websites.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Pharmaceutical


Does a health psychology approach hold the key to Rx adherence? In MM&M's latest Leadership Exchange Uncut eBook, industry stakeholders from the payer, provider, academic and pharma realms explore the "why" behind medicine taking. Access here.